Cardinal Health (NYSE:CAH) Trading Down 7.8% - What's Next?

Key Points

• Shares of Cardinal Health plunged about 7.8% intraday to roughly $187 on Thursday, trading below average volume after a prior close of $202.82.
• The company reported a non‑GAAP EPS beat ($3.17 vs. $2.80), raised and narrowed FY‑2026 non‑GAAP EPS guidance to $10.70–$10.80, and completed an additional $250M buyback while reducing debt, actions that support the medium‑term outlook.
• Offsetting those positives, Q3 revenue missed expectations ($60.94B vs. ~ $62.2B) and a $184M pre‑tax goodwill impairment pressured GAAP operating earnings and EPS, explaining the short‑term selling pressure.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) shares were down 7.8% on Thursday . The stock traded as low as $188.66 and last traded at $187.0190. Approximately 1,080,529 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 1,714,927 shares. The stock had previously closed at $202.82.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Non‑GAAP EPS beat consensus — adjusted EPS of $3.17 vs. estimates of $2.80, showing underlying operating strength. Cardinal Health (CAH) Q3 Earnings Beat Estimates
• Positive Sentiment: Management raised and narrowed FY‑2026 non‑GAAP EPS guidance to $10.70–$10.80 (above Street consensus), indicating confidence in specialty‑drug demand and supporting medium‑term earnings outlook. Cardinal Health lifts annual profit forecast on strong demand for specialty drugs
• Positive Sentiment: Share repurchases and balance‑sheet actions: Cardinal completed an additional $250M buyback (bringing FY26 repurchases to $1.0B) and reduced debt, which supports shareholder value. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook
• Positive Sentiment: Analyst interest: fresh/positive analyst coverage (e.g., William Blair initiation with an outperform) may support longer‑term sentiment. William Blair initiates coverage of Cardinal Health (CAH) with outperform recommendation
• Neutral Sentiment: Non‑GAAP operating metrics improved year‑over‑year (non‑GAAP operating earnings +18%, non‑GAAP EPS +35%), showing operational improvement though not fully offsetting GAAP impacts. Cardinal Health Posts Strong Q3 2026 Non-GAAP Results
• Neutral Sentiment: Company released slides and a conference‑call transcript — useful for digging into segment trends and margin drivers. Listen to Conference Call / View Press Release and Slide Deck
• Negative Sentiment: Revenue missed expectations — Q3 revenue $60.94B vs. consensus ~ $62.2B — creating concern that top‑line momentum is weaker than investors wanted. Why Is Cardinal Health Stock Sinking Thursday?
• Negative Sentiment: GAAP profit metrics were hurt by a $184M pre‑tax goodwill impairment (Navista & ION), driving a 30% drop in GAAP operating earnings and a 20% decline in GAAP EPS to $1.69 — a headline risk for investors focused on reported EPS. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook
• Negative Sentiment: Mixed signals — strong guidance and buybacks may not be enough to offset disappointment on revenue and GAAP items in the short term, explaining intraday selling pressure. Cardinal Health (CAH) Reports Q1: Everything You Need To Know Ahead Of Earnings

Analysts Set New Price Targets

Several research analysts have weighed in on CAH shares. Robert W. Baird set a $252.00 price target on shares of Cardinal Health in a research report on Friday, February 6th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday, April 12th. TD Cowen increased their price target on shares of Cardinal Health from $233.00 to $251.00 and gave the stock a "buy" rating in a research report on Wednesday, February 11th. JPMorgan Chase & Co. increased their price target on shares of Cardinal Health from $209.00 to $243.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 10th. Finally, William Blair assumed coverage on shares of Cardinal Health in a research report on Tuesday. They issued an "outperform" rating on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $244.33.

Cardinal Health Stock Down 6.1%

The company has a market capitalization of $44.81 billion, a PE ratio of 27.39, a PEG ratio of 1.30 and a beta of 0.64. The company's 50 day moving average is $214.32 and its two-hundred day moving average is $205.55.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.80 by $0.37. The company had revenue of $60.94 billion during the quarter, compared to analysts' expectations of $62.21 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. Cardinal Health's quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the company posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts forecast that Cardinal Health, Inc. will post 10.32 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 29.35%.

Hedge Funds Weigh In On Cardinal Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Strategy Asset Managers LLC purchased a new position in shares of Cardinal Health in the 3rd quarter worth $775,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Cardinal Health by 15.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company's stock worth $5,938,000 after purchasing an additional 5,030 shares during the period. Versor Investments LP purchased a new position in shares of Cardinal Health during the 3rd quarter worth about $2,090,000. Atle Fund Management AB boosted its stake in shares of Cardinal Health by 13.1% during the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company's stock worth $4,755,000 after purchasing an additional 3,500 shares during the period. Finally, Nordea Investment Management AB boosted its stake in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company's stock worth $133,741,000 after purchasing an additional 494,731 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.